-
Temple, B, Nation, ML, Dai, VTT, Beissbarth, J, Bright, K, Dunne, EM, Hinds, J, Hoan, PT, Lai, J, Nguyen, CD, et al.
Effect of a 2+1 schedule of ten-valent versus 13-valent pneumococcal conjugate vaccine on pneumococcal carriage: Results from a randomised controlled trial in Vietnam..
Vaccine
39(16)
:
2303 -2310
2021
view publication
-
Beissbarth, J, Wilson, N, Arrowsmith, B, Binks, MJ, Oguoma, VM, Lawrence, K, Llewellyn, A, Mulholland, EK, Santosham, M, Morris, PS, et al.
Nasopharyngeal carriage of otitis media pathogens in infants receiving 10-valent non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV10), 13-valent pneumococcal conjugate vaccine (PCV13) or a mixed primary schedule of both vaccines: A randomised controlled trial..
Vaccine
39(16)
:
2264 -2273
2021
view publication
-
Leach, AJ, Mulholland, EK, Santosham, M, Torzillo, PJ, McIntyre, P, Smith-Vaughan, H, Wilson, N, Arrowsmith, B, Beissbarth, J, Chatfield, MD, et al.
Interchangeability, immunogenicity and safety of a combined 10-valent pneumococcal Haemophilus influenzae protein D conjugate vaccine (Synflorix) and 13-valent-PCV (Prevenar13) schedule at 1-2-4-6 months: PREVIX_COMBO, a 3-arm randomised controlled trial..
Vaccine X
7:
100086
2021
view publication
-
Toh, ZQ, Russell, FM, Garland, SM, Mulholland, EK, Patton, G, Licciardi, PV.
Human Papillomavirus Vaccination After COVID-19..
JNCI Cancer Spectr
5(2)
:
pkab011
2021
view publication
-
Leach, AJ, Mulholland, EK, Santosham, M, Torzillo, PJ, McIntyre, P, Smith-Vaughan, H, Wilson, N, Arrowsmith, B, Beissbarth, J, Chatfield, MD, et al.
Otitis media outcomes of a combined 10-valent pneumococcal Haemophilus influenzae protein D conjugate vaccine and 13-valent pneumococcal conjugate vaccine schedule at 1-2-4-6 months: PREVIX_COMBO, a 3-arm randomised controlled trial..
BMC Pediatr
21(1)
:
117
2021
view publication